ArticleClinical and translational science2023

Systems-based digital twins to help characterize clinical dose-response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHL.

Monica E Susilo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.